FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

  • COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

    PARTNER ARTICLES

    Back to Top